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CONTRIBUTION
What are the novel findings of this work?
The association between two-dimensional perineal and
three-dimensional endovaginal ultrasound findings and
patient symptoms in a cohort of women with mid-urethral
sling (MUS) complications has not been shown before.
MUS position within the rhabdosphincter and C-shaped
MUS both at rest and on Valsalva maneuver were
associated with voiding dysfunction. MUS position in the
distal third of the urethra was associated with a higher
incidence of recurrent urinary tract infection.
What are the clinical implications of this work?
This study adds to the limited body of evidence for
best practice in the assessment of complications after
MUS placement. As recurrent urinary tract infection and
voiding dysfunction appear to be related to tape location,
care needs to be taken during MUS insertion to ensure
correct placement.
ABSTRACT
Objectives To present the characteristics of women
attending a tertiary urogynecology pelvic floor scan clinic
with mid-urethral sling (MUS) complications and examine
the association between patient symptoms and findings
on two-dimensional (2D) perineal and three-dimensional
(3D) endovaginal ultrasound.
Methods This was a cross-sectional study of all women
with MUS complications referred to a specialist pelvic
floor ultrasound clinic between October 2016 and
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October 2018. Detailed history was obtained regard-
ing their symptoms and time of onset. All patients
underwent 2D perineal and 3D endovaginal ultrasound
assessment. The association between patient symptoms
and ultrasound findings was evaluated using logistic
regression analysis. Only symptomatic women with a
single MUS, without other pelvic floor mesh, prior
mesh excision or bulking agents, were included in the
regression analysis.
Results A total of 311 women with a history of MUS
surgery were seen during the study period. Vaginal
and/or non-vaginal pain was reported by 80% of patients
and this was the primary presenting complaint in 59%
of the patients. One-third of the patients reported
symptoms starting within 4 weeks after surgery. The
data of 172 patients were included in the regression
analysis. MUS position within the rhabdosphincter was
significantly associated with voiding dysfunction (odds
ratio (OR), 10.6 (95% CI, 2.2–50.9); P = 0.003). Voiding
dysfunction was highest in those with C-shaped MUS both
at rest and on Valsalva maneuver (OR, 3.2 (95% CI,
1.3–7.6); P < 0.001). MUS position in the distal third of
the urethra was significantly associated with a higher rate
of recurrent urinary tract infection (OR, 2.9 (95% CI,
1.3–6.3); P = 0.01).
Conclusions Pelvic floor ultrasound can provide insight
into the position and shape of the MUS, which could
explain some patient symptoms and guide management
or surgical planning. © 2020 The Authors. Ultrasound
in Obstetrics & Gynecology published by John Wiley &
Sons Ltd on behalf of International Society of Ultrasound
in Obstetrics and Gynecology.
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INTRODUCTION
The controversy surrounding the use of mesh for the
treatment of pelvic floor dysfunction continues, with a
growing number of patients presenting with complica-
tions attributed to mesh1. Associated symptoms include
mesh extrusion, infection, chronic pain and sexual
dysfunction2,3, as well as ongoing disability following
removal4. As pelvic floor ultrasound is increasingly being
utilized within urogynecology5, its usefulness in investi-
gating mesh complications is gradually being recognized6.
However, there are still large gaps in our understanding
of its full clinical applicability. Although clinical exami-
nation has been shown to be superior to ultrasound in
diagnosing vaginal mesh extrusion7, assessment of other
features of the mesh implant, such as its precise location
and its position in relation to neighboring structures,
may provide valuable information for surgical planning
or investigating complex symptoms. Ultrasound is the
only imaging modality that can clearly visualize the mesh
in the pelvic floor, owing to its echogenicity6. Research
to date has mostly utilized three- and four-dimensional
(3D/4D) transperineal or translabial modalities8–11.
Perineal pelvic floor ultrasound (pPFUS) allows dynamic
assessment of mid-urethral slings (MUS) and is performed
using curvilinear probes, which are widely available in
most gynecology departments. Although 3D endovaginal
ultrasound (EVUS) requires specialist equipment, it offers
reliable, high-resolution imaging of the whole pelvic
floor12. It is useful in the diagnosis of posterior compart-
ment disorders and pelvic organ prolapse13,14, evaluation
of the location and distribution of urethral bulking
agents15,16, assessment of the presence and location of
mesh for prolapse and associated complications17 and
diagnosis of urethrovaginal fistulas and vaginal cysts18,19.
The benefits of the technique are its simplicity and ability
to provide high-resolution images owing to the close
proximity to the pelvic structures, and it is associated
with excellent interobserver agreement20. Analysis of
the 3D volume allows assessment of mesh morphology
and the adjacent pelvic anatomy, providing patients and
clinicians with the opportunity to visualize the entire
















Figure 1 Honeycomb appearance of mesh (labeled ‘Tape’) on three-dimensional endovaginal ultrasound (a,b) and two-dimensional
transperineal pelvic floor ultrasound (c).
We hypothesize that MUS location can contribute to
patient symptoms and therefore that ultrasound is a useful
adjunctive investigation when assessing women presenting
with complications following mesh incontinence surgery.
The objective of this study was to present the character-
istics of women with a history of MUS surgery attending
a tertiary urogynecology pelvic floor ultrasound clinic
and to examine the association between their symptoms
and two-dimensional (2D) pPFUS and 3D EVUS findings.
METHODS
This was a cross-sectional study of all women presenting
to a tertiary urogynecology pelvic floor ultrasound clinic
for MUS complications from October 2016 to October
2018. For all patients, a detailed history was taken
regarding their symptoms and time of onset, including
subjective presence of pain, urinary, bowel and pro-
lapse symptoms and details of previous surgical history.
Non-vaginal pain was considered any pain reported in the
back, groin, abdomen or legs. Exclusion criteria from the
analysis of the association between ultrasound findings
and patient symptoms were the presence of more than one
MUS, other pelvic mesh or urethral bulking agent, prior
partial or complete MUS excision or being asymptomatic.
2D pPFUS and 3D EVUS, both validated imaging tech-
niques, were performed according to standardized meth-
ods using a Flex Focus 500 ultrasound system (BK Med-
ical, Herlev, Denmark)5,7. All scans were performed and
analyzed by, or directly supervised by, the senior author
(R.T.). The methodology for performing the scans has
been reported previously21. The mesh was identified by
its characteristic honeycomb-like appearance (Figure 1).
For 2D pPFUS, a convex transducer (4.3–6 MHz, Type
8802; BK Medical) was placed over the labia of the
patient. A mid-sagittal image was obtained with the
transducer in a vertical position, to evaluate the distance
between the mesh implant and the symphysis pubis, as
well as the mesh shape at rest and on maximum Valsalva
maneuver. The mid-point of the MUS was taken as the
reference point for measurements. The transducer was
rotated 90◦ to a horizontal position to assess for curling
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2021; 57: 639–646.
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or folding. This was diagnosed subjectively as an obvious
non-flat or non-linear appearance of the mesh implant.
The distance from the MUS to the symphysis pubis was
measured (in mm) from the center of the MUS to the tip of
the symphysis pubis seen on mid-sagittal view (Figure 2).
The shape of the MUS was assessed in the mid-sagittal
view, at rest and on maximum Valsalva maneuver. MUS
shapes were categorized as Type 1 (flat shape both at
rest and on Valsalva maneuver), Type 2 (flat at rest and
C-shaped on Valsalva) or Type 3 (C-shaped both at rest
and on Valsalva), as previously reported (Figure 2)22.
3D EVUS was performed at rest using a Type 8838,





Figure 2 Mid-sagittal two-dimensional transperineal pelvic floor
ultrasound image obtained at rest, showing C-shaped mid-urethral
sling (MUS) (labeled ‘Tape’). Distance from center of MUS to pubic
symphysis (dashed double-headed arrow) was measured. When
MUS maintains its C-shaped appearance on Valsalva maneuver, it
is considered to have C-to-C (Type 3) shape.
3D volume allowed assessment of the type and position
of the MUS in the sagittal, coronal and axial planes. The
following measurements were obtained in the mid-sagittal
view: urethral length (in mm) from the bladder neck to
the urethral meatus (Figure 3) and distance from the MUS
to the bladder neck (in mm), measured from the midpoint
of the MUS to the level of the bladder neck, parallel to
the urethral lumen (Figure 3). The position of the MUS
along the urethra was then calculated as a percentage of
the urethral length and reported according to its location
in the proximal third, middle third or distal third of the
urethra. The distance from the MUS to the urethral lumen
was then measured from the middle of the MUS to the
center of the urethral lumen (in mm) (Figure 3).
In addition, the following were evaluated: (1) folding
of the mesh implant was assessed by reviewing the 3D
volume in the coronal, sagittal and axial planes (Figure 4);
(2) mesh proximity to the urethral rhabdosphincter or




Figure 3 Mid-sagittal endovaginal ultrasound image showing
measurement of: urethral length from beaked bladder neck to
urethral meatus (dotted line); distance from mid-urethral sling
(labeled ‘Tape’) to bladder neck (solid white line); distance from









Figure 4 Three-dimensional endovaginal ultrasound images (axial plane) showing folding/curling of mid-urethral sling (labeled ‘Tape’ in (a))
beneath urethra. Tape is highlighted (yellow) in (b).
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volume in the coronal, sagittal and axial planes; and
(3) the type of MUS was determined by observing the
direction of the MUS arms: a transobturator tape was
diagnosed if the arms were traced laterally into the
obturator foramen, and a retropubic mid-urethral sling if
the arms traversed upwards towards the pubic bone6.
Institutional research and development approval was
obtained for this study (YLC/MC/PFU2) and ethical
approval was not deemed necessary.
Statistical analysis
Only symptomatic patients with a single intact MUS
were included in the analysis of the association between
ultrasound findings and symptoms. Patients’ symptoms
were considered as binary variables, either present or
absent. Logistic regression analysis was performed both
unadjusted and then re-examining the relationships
adjusting for predetermined patient and treatment factors
(age, previous prolapse repair, history of MUS extrusion,
time since MUS insertion, presence of pelvic organ
prolapse and type of MUS inserted). The size effects of
each variable with the outcome were summarized as odds
ratios (ORs). For categorical variables, ORs give the
odds of the symptom relative to the odds in a baseline
category. For continuous variables, ORs represent the
relative change in the odds of the symptoms for a one-unit
increase in each variable (other-sized increases shown
when one-unit increase was too small). Each ultrasound
factor was examined in separate analyses and P < 0.05
was considered to indicate statistical significance.
RESULTS
Over the 2-year study period, 311 women with a
reported history of MUS insertion were seen in our pelvic
floor ultrasound clinic. The indications for pelvic floor
ultrasound were localization of MUS in 243 women
(78%) and localization of MUS remnant in 68 (22%).
Twenty (6%) patients had had two MUSs inserted.
Further concomitant procedures are listed in Table 1.
Reported complications at the time of surgery or within
24 h occurred in 32/311 (10%) patients and included:
acute retention in 22 (7%), bladder injury in five
(2%), sepsis in two (1%), hemorrhage in one (0.3%),
hematoma formation in one (0.3%) and bowel injury in
one (0.3%). Presenting symptoms starting within 4 weeks
after MUS insertion were reported by 98/311 (32%)
patients. The primary presenting symptom was chronic,
non-localized pain in 182/311 (59%) women. Details
of all other presenting and concomitant symptoms are
shown in Table 1. In total, 249/311 (80%) reported any
pain (vaginal and/or non-vaginal) either as a primary or
concomitant complaint.
The primary scan outcomes were: the shape/type/
position of a MUS was depicted in 225 (72%) patients,
the absence or presence and location of MUS remnants
was diagnosed in 68 (22%), unexpected presence or
absence of MUS or bulking agent or other pelvic floor
Table 1 Presenting symptoms and surgical history of 311 women
attending pelvic floor ultrasound clinic with reported history of
mid-urethral sling (MUS) insertion
Patient history Value
Main presenting complaint
Non-localized pain 182 (59)
Persistent SUI 38 (12)
Recurrent urinary tract infection 22 (7)
Voiding dysfunction 20 (6)
Mesh extrusion 17 (5)
Asymptomatic but seeking reassurance 12 (4)
Dyspareunia 8 (3)
Vaginal lump 5 (2)
Recurrent SUI 5 (2)
Vaginal bleeding 2 (1)
Concurrent symptoms
Pain in back, groin, abdomen or legs 216 (69)
Vaginal pain 148 (48)
Urinary urgency 134 (43)
SUI 97 (31)
Voiding difficulty 92 (30)
Recurrent urinary tract infection 84 (27)
Bowel symptoms 57 (18)
Hispareunia 20 (6)
Vaginal discharge 10 (3)
Surgical history*
MUS excision or division (partial or full) 108 (35)
Hysterectomy 93 (30)
Over-sewing or trimming for extrusions 80 (26)
Native-tissue prolapse repair 27 (9)
Two MUSs 20 (6)
Urethral bulking procedure 15 (5)
Anterior repair with mesh 9 (3)
Posterior repair with mesh 9 (3)
Sacrohysteropexy 7 (2)
Mesh rectopexy 3 (1)
Data are given as n (%). *Some patients had more than one
surgical procedure. SUI, stress urinary incontinence.
mesh was identified in nine (3%), a previously unknown
vaginal mesh exposure was diagnosed in seven (2%) and
previously unknown organ extrusion was diagnosed in
two (1%).
A total of 172 symptomatic women with a single MUS
were included in the analysis of the association between
ultrasound findings and patient symptoms (Figure 5).
Their mean age was 54.1 ± 9.9 years and the median
time since MUS insertion was 8 years (interquartile range,
4–10 years).
Table 2 shows the association between patient symp-
toms and ultrasound findings. Adjusting for confounding
variables did not affect the results, so only the unadjusted
ORs have been presented.
MUS position within the rhabdosphincter was signif-
icantly associated with voiding dysfunction (OR, 10.6
(95% CI, 2.2–50.9); P = 0.003). The odds of voiding
dysfunction were over 10 times higher if the MUS
was within the rhabdosphincter. Unadjusted analysis
suggested that the incidence of stress urinary incontinence
would be lower if the MUS was positioned within the
rhabdosphincter.
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2021; 57: 639–646.
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Women with reported history of
MUS insertion
(n = 311)
Excluded (n = 139)*:
 Two MUSs (n = 20)
 Other additional mesh present:
  Mesh rectopexy/hysteropexy (n = 10)
  Anterior vaginal wall mesh (n = 9)
  Posterior vaginal wall mesh (n = 9)
 Urethral bulking agents (n = 15)
 Previous partial or complete MUS
  removal/excision (n = 108)
Confounding characteristics:
 Previous POP repair (n = 47)
 Known vaginal mesh extrusion (n = 10)
 POP present (n = 56)
 Type of tape:
 Retropubic tape (n = 117)
 Transobturator tape (n = 55)
Symptomatic women with
single, intact MUS, without
other mesh or bulking agents
(n = 172)
Figure 5 Flowchart showing inclusion of symptomatic patients with single mid-urethral sling (MUS) in final analysis evaluating association
between sonographic findings and symptoms. *Some patients had more than one exclusion criteria. POP, pelvic organ prolapse.
The incidence of voiding dysfunction was highest in
women with MUS shape Type 3 (C-shaped at rest and
on Valsalva), occurring in 64% of these patients. In
contrast, only 36% of patients with MUS shape Type 1
(flat at rest and on Valsalva) had voiding dysfunction.
The unadjusted analysis suggested that the likelihood of
voiding dysfunction was 3.2 times higher in patients with
Type-3 than in those with Type-1 MUS shape.
Patients with MUS located in the proximal third and
those with MUS located in the middle third of the urethra
were analyzed together because of the small number of
patients with a proximally located MUS. Distal MUS
position in relation to urethral length was significantly
associated with a higher incidence of recurrent urinary
tract infection (OR, 2.9 (95% CI, 1.3–6.3); P = 0.01)
compared with proximal or mid-urethral MUS position.
The odds of recurrent urinary tract infection were over
twice as high in the group with a distal MUS position,
compared with the group with a proximal or mid-urethral
position, for both the unadjusted and adjusted analyses.
No ultrasound features or measurements were asso-
ciated with urinary urgency, vaginal or back/groin/
abdominal/leg pain or dyspareunia either before or after
adjusting for patient and treatment factors.
DISCUSSION
The objective of this study was to present the
characteristics of women with a history of MUS surgery
attending a specialist pelvic floor scan clinic and examine
the association between ultrasound findings and their
symptoms. The most common presenting complaint
was non-localized, chronic pain, which in one-third of
the patients started within 4 weeks after surgery. MUS
position within the rhabdosphincter and MUS shape
Type 3 were associated with voiding dysfunction. Distal
position of the MUS in relation to the urethral length was
associated with a higher rate of recurrent urinary tract
infection.
Pain has been reported to be the most common
mesh-related complaint, along with dyspareunia7,23. It
is therefore unsurprising that 80% of our cohort
reported vaginal and/or non-vaginal pain. Owing to its
multifactorial etiology and the frequent coexistence of
comorbidities, it is difficult to ascertain the prevalence of
pain attributed directly to mesh. In contrast to previous
reports24, we found no association between pain (vaginal
or non-vaginal) and MUS folding or proximity to the
urethral rhabdosphincter. This may be explained by a
lack of specification of the type or location of pain.
Many of the patients in our cohort had complex surgical
histories with multiple urogynecological procedures,
highlighting the value of pelvic floor ultrasound. Although
clinical examination has been shown to be superior to
ultrasound for identifying mesh extrusion, ultrasound is
best for diagnosing visceral involvement7 and identifying
organ extrusion or exposure (3% of our patients), and
it contributes to the holistic management. Ultrasound
findings influence the counseling process and subsequent
surgical planning; in 6% of the women in our cohort, the
MUS was positioned within the rhabdosphincter, which
could increase the risk of urethroplasty during revision
surgery. The finding that one-third of women developed
symptoms in the short postoperative period suggests that
close follow-up, specifically within the first 4 weeks, may
be beneficial. The nationally proposed surgical databases
in the UK could aid in such monitoring and tracking1.
Few of our findings complement those reported
previously using 3D/4D ultrasound. Kocisziewski et al.9
utilized a translabial approach to describe optimal MUS
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2021; 57: 639–646.
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Table 2 Association between patient symptoms and findings on
two-dimensional perineal pelvic floor ultrasound and three-











Distance to urethral lumen — 1.1 (1.0–1.4) 0.2
Distance to symphysis pubis† — 1.2 (0.8–1.7) 0.4
Position along urethra
Proximal or middle 44/140 (31) 1.0 0.3
Distal 7/32 (22) 0.6 (0.3–1.5)
Placement in rhabdosphincter
No 51/161 (32) ‡ 0.04
Yes 0/11 (0)
Curling/folding
No 40/137 (29) 1.0 0.8
Yes 11/35 (31) 1.1 (0.5–2.5)
MUS shape§
Type 1 19/56 (34) 1.0 0.7
Type 2 22/80 (28) 0.7 (0.4–1.6)
Type 3 10/36 (28) 0.8 (0.3–1.9)
Urinary urgency
Distance to urethral lumen — 1.1 (1.0–1.3) 0.2
Distance to symphysis pubis† — 0.9 (0.7–1.3) 0.7
Position along urethra
Proximal or middle 67/140 (48) 1.0 0.2
Distal 11/32 (34) 0.6 (0.3–1.3)
Placement in rhabdosphincter
No 74/161 (46) 1.0 0.5
Yes 4/11 (36) 0.7 (0.2–2.4)
Curling/folding
No 64/137 (47) 1.0 0.5
Yes 14/35 (40) 0.8 (0.4–1.6)
MUS shape§
Type 1 26/56 (46) 1.0 0.3
Type 2 32/80 (40) 0.8 (0.4–1.5)
Type 3 25/36 (69) 1.4 (0.6–3.4)
Voiding dysfunction
Distance to urethral lumen — 0.8 (0.7–1.0) 0.07
Distance to symphysis pubis† — 0.9 (0.6–1.4) 0.7
Position along urethra
Proximal or middle 46/140 (33) 1.0 0.9
Distal 11/32 (34) 1.1 (0.5–2.4)
Placement in rhabdosphincter
No 48/161 (30) 1.0 0.003
Yes 9/11 (82) 10.6 (2.2–50.9)
Curling/folding
No 46/137 (34) 1.0 0.8
Yes 11/35 (31) 0.9 (0.4–2.0)
MUS shape§
Type 1 20/56 (36) 1.0 < 0.001
Type 2 14/80 (18) 0.4 (0.2–0.9)
Type 3 23/36 (64) 3.2 (1.3–7.6)
Recurrent urinary tract infection
Distance to urethral lumen — 0.9 (0.7–1.1) 0.2
Distance to symphysis pubis† — 1.2 (0.8–1.7) 0.4
Position along urethra
Proximal or middle 33/140 (24) 1.0 0.01
Distal 15/32 (47) 2.9 (1.3–6.3)
Placement in rhabdosphincter
No 43/161 (27) 1.0 0.2
Yes 5/11 (45) 2.3 (0.7–7.9)
Curling/folding
No 39/137 (28) 1.0 0.8











Type 1 16/56 (29) 1.0 0.4
Type 2 19/80 (24) 0.8 (0.4–1.7)
Type 3 13/36 (36) 1.4 (0.6–3.5)
Vaginal pain
Distance to urethral lumen — 1.0 (0.9–1.2) 0.7
Distance to symphysis pubis† — 0.9 (0.6–1.2) 0.4
Position along urethra
Proximal or middle 51/140 (36) 1.0 0.9
Distal 12/32 (38) 1.1 (0.5–2.3)
Placement in rhabdosphincter
No 60/161 (37) 1.0 0.5
Yes 3/11 (27) 0.6 (0.2–2.5)
Curling/folding
No 51/137 (37) 1.0 0.8
Yes 12/35 (34) 0.9 (0.4–1.9)
MUS shape§
Type 1 21/56 (38) 1.0 0.7
Type 2 27/80 (34) 0.9 (0.4–1.7)
Type 3 15/36 (42) 1.2 (0.5–2.8)
Back/groin/abdomen/leg pain
Distance to urethral lumen — 1.0 (0.9–1.2) 0.9
Distance to symphysis pubis† — 1.1 (0.8–1.6) 0.6
Position along urethra
Proximal or middle 93/140 (66) 1.0 0.6
Distal 23/32 (72) 1.3 (0.6–3.0)
Placement in rhabdosphincter
No 108/161 (67) 1.0 0.7
Yes 8/11 (73) 1.3 (0.3–5.1)
Curling/folding
No 92/137 (67) 1.0 0.9
Yes 24/35 (69) 1.1 (0.5–2.4)
MUS shape§
Type 1 40/56 (71) 1.0 0.6
Type 2 51/80 (64) 0.7 (0.3–1.5)
Type 3 25/36 (69) 0.9 (0.4–2.3)
Dyspareunia
Distance to urethral lumen — 1.1 (0.9–1.3) 0.3
Distance to symphysis pubis† — 0.9 (0.6–1.3) 0.6
Position along urethra
Proximal or middle 68/140 (49) 1.0 0.2
Distal 12/32 (38) 0.6 (0.3–1.4)
Placement in rhabdosphincter
No 75/161 (47) 1.0 0.6
Yes 6/11 (55) 1.4 (0.4–4.7)
Curling/folding
No 62/137 (45) 1.0 0.3
Yes 19/35 (54) 1.4 (0.7–3.0)
MUS shape§
Type 1 28/56 (50) 1.0 0.7
Type 2 38/80 (48) 0.9 (0.5–1.8)
Type 3 15/36 (42) 0.7 (0.3–1.7)
*Adjusted analysis for confounders (age, previous prolapse repair,
history of MUS extrusion, time since MUS insertion, presence of
prolapse and type of tape) did not affect results. †Odds ratio given
for 5-unit increase in variable. ‡Unable to calculate odds ratios
owing to no occurrences of outcome in one category; unadjusted
analysis using Fisher’s exact test. §Type 1, flat MUS shape at rest
and remains flat on Valsalva maneuver; Type 2, flat MUS shape at
rest and C-shaped on Valsalva maneuver; Type 3, C-shaped MUS
at rest and remains C-shaped on Valsalva maneuver.
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2021; 57: 639–646.
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position to be at 40–70% of the urethral length. Using
3D EVUS to assess MUS failures, Bogusiewicz et al.25
found positioning in the proximal half of the urethra
to be associated with MUS failure. Our study did not
find similar associations; this could be owing to the low
number (n = 4) of cases with proximally located MUS in
our cohort and because our study involved a different
cohort of women. We did however find that placement in
the distal third of the urethra is associated with recurrent
urinary tract infection, which has previously not been
reported and needs further exploration in larger cohorts.
This information could guide a decision to surgically
intervene when a patient presents with recurrent urinary
tract infections and their MUS is distally placed. Other
authors, using 3D pPFUS, have found no association
between MUS position in relation to the urethral length
and complications, symptoms or success8,10.
Our finding that MUS shape Type 3 (C-shaped at rest
and on Valsalva) is associated with voiding dysfunction
corroborate those previously described by Kociszewski
et al.22 using translabial ultrasound. We did not find
an association between stress urinary incontinence and
MUS shape Type 1 (flat shape at rest and on Valsalva
maneuver). This may be owing to our varied follow-up
period, as opposed to the 42-month follow-up in the
study of Kocisziewski et al.22 and the differing study
populations and presenting complaints.
The effect of proximity of the MUS to the urethral
lumen on symptoms of voiding and stress incontinence is
theoretically plausible. Similarly to Kociswewski et al.9,
we also found reduced voiding dysfunction with MUS
further from the urethral lumen. This is also supported by
our finding of MUS location within the rhabdosphincter
(which encircles the urethral lumen) being associated
with voiding dysfunction, suggesting undue compression
of the urethral lumen. This could influence a decision
to offer division of the MUS if a patient presents
with voiding dysfunction. Although we did not find an
association between symptoms and distance of the MUS
to the symphysis pubis on 2D perineal ultrasound, it has
previously been reported that a narrower gap between
the MUS and the symphysis pubis on 3D/4D perineal
ultrasound is associated with a greater cure of stress
urinary incontinence26.
Logically, folding of the MUS would suggest reduced
tension in the tape and therefore persistent stress urinary
incontinence, however, surprisingly, we did not find this.
To date, no studies have been able to find such an
association.
Our study has some limitations. The retrospective
nature of ascertaining patient history may have introduced
recall bias, particularly as mesh is a topical issue in the
media. We were not able to corroborate surgical history
with hospital records, as most women had their primary
surgery in other hospitals. In addition, those with severe
symptoms, such as urinary retention, may have had their
MUS partially excised, and as these patients were excluded
from the analysis of association between symptoms and
sonographic findings, this may have skewed the results. It
is therefore unlikely that these results will be generalizable
to asymptomatic women with MUS. We did not assess
symptoms by validated questionnaires or confirm them
using objective tests, therefore, patients’ reported histories
and symptoms are subjective. Physical examination was
not performed, therefore localized vaginal pain is difficult
to confirm and confounding variables such as levator
spasm or prolapse may have been present. Owing to the
high prevalence of pain in our cohort, it was difficult
to determine an association between ultrasound findings
and pain, which is a multifactorial, subjective and diffuse
symptom. Therefore, to distinguish sonographic findings
attributable only to pain would require comparison with
a cohort of asymptomatic women in a larger study. It has
been suggested that migration of the MUS can occur with
time, both towards the bladder neck27 and the urethral
lumen9. Our ultrasound examination was performed at a
single timepoint, but more complex associations affected
by time since surgery may be possible.
This study reiterates the potential clinical use of 2D
pPFUS and 3D EVUS in identifying the presence and
location of MUS, MUS remnants and exposure/extrusion,
particularly to guide surgical planning, need for additional
investigations and patient counseling. This is particularly
the case as most women will present with their compli-
cations to a clinician other than their primary surgeon28.
Our findings suggest an association between voiding
dysfunction and recurrent urinary tract infections and
certain ultrasound findings. This study could lead
towards the standardization of measurements made
during pelvic floor ultrasound, when performed for MUS
complications.
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